Yoshikuni Nagashio

765 total citations
61 papers, 404 citations indexed

About

Yoshikuni Nagashio is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yoshikuni Nagashio has authored 61 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 39 papers in Pulmonary and Respiratory Medicine and 35 papers in Oncology. Recurrent topics in Yoshikuni Nagashio's work include Gallbladder and Bile Duct Disorders (33 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Pediatric Hepatobiliary Diseases and Treatments (19 papers). Yoshikuni Nagashio is often cited by papers focused on Gallbladder and Bile Duct Disorders (33 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Pediatric Hepatobiliary Diseases and Treatments (19 papers). Yoshikuni Nagashio collaborates with scholars based in Japan, Philippines and United States. Yoshikuni Nagashio's co-authors include Makoto Otsuki, Masashi Taguchi, Mitsuo Tashiro, Susumu Hijioka, Shiro Watanabe, Takuji Okusaka, Yuta Maruki, Taizo Yamaguchi, Yasuyuki Kihara and Hayato Nakamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and International Journal of Molecular Sciences.

In The Last Decade

Yoshikuni Nagashio

45 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshikuni Nagashio Japan 13 310 230 138 72 42 61 404
Seitaro Watanabe Japan 13 260 0.8× 193 0.8× 179 1.3× 63 0.9× 23 0.5× 38 425
Ursula Pauser Germany 11 506 1.6× 451 2.0× 132 1.0× 201 2.8× 9 0.2× 16 701
Takahiro Yoshizawa Japan 10 83 0.3× 193 0.8× 104 0.8× 36 0.5× 23 0.5× 43 305
Jean-François Fléjou France 10 85 0.3× 100 0.4× 68 0.5× 51 0.7× 15 0.4× 14 267
Daniela Betea Belgium 12 180 0.6× 161 0.7× 70 0.5× 146 2.0× 10 0.2× 28 611
Shun Ishiyama Japan 10 138 0.4× 100 0.4× 102 0.7× 31 0.4× 9 0.2× 98 322
Kenji Okubo Japan 10 298 1.0× 267 1.2× 193 1.4× 84 1.2× 5 0.1× 24 457
Thomas Wittmann Germany 13 268 0.9× 70 0.3× 191 1.4× 199 2.8× 28 0.7× 25 478
Regina Lamberts Germany 9 350 1.1× 78 0.3× 95 0.7× 153 2.1× 14 0.3× 13 550
Lan Mu China 11 139 0.4× 153 0.7× 96 0.7× 56 0.8× 41 1.0× 33 362

Countries citing papers authored by Yoshikuni Nagashio

Since Specialization
Citations

This map shows the geographic impact of Yoshikuni Nagashio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshikuni Nagashio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshikuni Nagashio more than expected).

Fields of papers citing papers by Yoshikuni Nagashio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshikuni Nagashio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshikuni Nagashio. The network helps show where Yoshikuni Nagashio may publish in the future.

Co-authorship network of co-authors of Yoshikuni Nagashio

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshikuni Nagashio. A scholar is included among the top collaborators of Yoshikuni Nagashio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshikuni Nagashio. Yoshikuni Nagashio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruki, Yuta, Chigusa Morizane, Yoshikuni Nagashio, et al.. (2025). First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. International Journal of Molecular Sciences. 26(12). 5586–5586.
2.
Hijioka, Susumu, Yoshikuni Nagashio, Yuta Maruki, et al.. (2024). Incidence and factors associated with stent dysfunction and pancreatitis after gastroduodenal stenting for malignant gastric outlet obstruction. SHILAP Revista de lepidopterología. 12(3). E367–E376. 2 indexed citations
4.
Maruki, Yuta, Susumu Hijioka, Yoshikuni Nagashio, et al.. (2024). Sedative effects of propofol and risk factors for excessive sedation in the endoscopic treatment of biliary and pancreatic diseases. SHILAP Revista de lepidopterología. 5(1). e417–e417. 3 indexed citations
6.
7.
Morizane, Chigusa, Noriko Tanabe, Yuta Maruki, et al.. (2023). Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. Pancreatology. 23(8). 964–969. 6 indexed citations
9.
Hijioka, Susumu, Yoshikuni Nagashio, Yuta Maruki, et al.. (2023). Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreaticobiliary Cancer Aiming for a Comprehensive Genome Profile. Diagnostics. 13(7). 1275–1275. 8 indexed citations
10.
Morizane, Chigusa, Yuta Maruki, Akihiro Ohba, et al.. (2022). The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancer. International Journal of Clinical Oncology. 27(8). 1331–1339.
11.
Hijioka, Susumu, Yoshikuni Nagashio, Akihiro Ohba, Yuta Maruki, & Takuji Okusaka. (2021). The Role of EUS and EUS-FNA in Differentiating Benign and Malignant Gallbladder Lesions. Diagnostics. 11(9). 1586–1586. 12 indexed citations
12.
Hijioka, Susumu, et al.. (2020). Simultaneous endoscopic ultrasound-guided hepaticogastrostomy and bridging stenting with partial stent-in-stent method. Endoscopy. 52(10). E381–E382. 1 indexed citations
13.
Maruki, Yuta, Susumu Hijioka, Akihiro Ohba, et al.. (2020). Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video). Gastrointestinal Endoscopy. 92(3). 763–769. 6 indexed citations
14.
Nagashio, Yoshikuni, et al.. (2016). Adenomyomatous hyperplasia of the lower bile duct mimicking a papillary bile duct tumor. Endoscopy. 48(S 01). E311–E312. 2 indexed citations
15.
Hijioka, Susumu, Kazuo Hara, Nobumasa Mizuno, et al.. (2014). A novel technique for endoscopic transpapillary “mapping biopsy specimens” of superficial intraductal spread of bile duct carcinoma (with videos). Gastrointestinal Endoscopy. 79(6). 1020–1025. 23 indexed citations
16.
Imaoka, Hiroshi, Nobumasa Mizuno, Yasuhiro Shimizu, et al.. (2013). Chemoradiotherapy versus chemotherapy in patients with locally advanced pancreatic cancer -a large single center study. Suizo. 28(1). 42–48. 1 indexed citations
17.
Taguchi, Masashi, Yasuyuki Kihara, Yoshikuni Nagashio, et al.. (2009). Decreased production of immunoglobulin M and A in autoimmune pancreatitis. Journal of Gastroenterology. 44(11). 1133–1139. 17 indexed citations
18.
Yamaguchi, Taizo, Yasuyuki Kihara, Masashi Taguchi, et al.. (2006). Persistent destruction of the basement membrane of the pancreatic duct contributes to progressive acinar atrophy in rats with experimentally-induced pancreatitis. Suizo. 21(4). 387–389. 2 indexed citations
19.
Nagashio, Yoshikuni, Hikaru Ueno, Michio Imamura, et al.. (2004). Inhibition of transforming growth factor β decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Laboratory Investigation. 84(12). 1610–1618. 65 indexed citations
20.
Nagashio, Yoshikuni, Shiro Watanabe, Masashi Taguchi, et al.. (2004). Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 287(1). G170–G177. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026